STOCKHOLDERS' EQUITY STATEMENTS (USD $) In Millions	Total		Common stock and paid-in capital	Retained earnings (deficit)	Accumulated other comprehensive income
Balance, beginning of period at Jun. 30, 2011			$ 63,415	$ (8,195)	$ 1,863
Common stock issued			1,924
Net income	16,978			16,978
Other comprehensive income (loss)	(441)				(441)
Common stock cash dividends				(6,721)
Common stock repurchased			(1,714)	(2,918)
Stock-based compensation expense			2,244
Stock-based compensation income tax benefits (deficiencies)			(75)
Other, net			3
Balance, end of period at Jun. 30, 2012	66,363		65,797	(856)	1,422
Common stock issued			920
Net income	21,863	[1],[2]		21,863
Other comprehensive income (loss)	321				321
Common stock cash dividends				(7,694)
Common stock repurchased			(2,014)	(3,418)
Stock-based compensation expense			2,406
Stock-based compensation income tax benefits (deficiencies)			190
Other, net			7
Balance, end of period at Jun. 30, 2013	78,944		67,306	9,895	1,743
Common stock issued			607
Net income	22,074	[2],[3]		22,074
Other comprehensive income (loss)	1,965				1,965
Common stock cash dividends				(9,271)
Common stock repurchased			(2,328)	(4,988)
Stock-based compensation expense			2,446
Stock-based compensation income tax benefits (deficiencies)			272
Other, net			63
Balance, end of period at Jun. 30, 2014	$ 89,784		$ 68,366	$ 17,710	$ 3,708

[1] Includes a charge related to a fine imposed by the European Commission in March 2013 which decreased net income by $733 million (€561 million) and diluted earnings per share by $0.09. Also includes a charge for Surface RT inventory adjustments recorded in the fourth quarter of fiscal year 2013, which decreased net income by $596 million and diluted earnings per share by $0.07.

[2] NDS has been included in our consolidated results of operations starting on April 25, 2014, the date of acquisition.

[3] Includes a tax provision adjustment recorded in the fourth quarter of fiscal year 2014 related to adjustments to prior years' liabilities for intercompany transfer pricing which decreased net income by $458 million and diluted earnings per share by $0.05.